Effect of reducing circulating free fatty acids on ventricular arrhythmias during myocardial infarction and on ST-segment depression during exercise-induced ischemia.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Circulation

• Publication date

  1976-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 767017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogue.

  1975cited by this paper
• Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction

  1975cited by this paper
• Influence of sodium palmitate on the cellular action of potentials of the left ventricle of isolated, perfused guinea-pig heart.

  1975cited by this paper
• Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

  1974cited by this paper
• Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs.

  1974cited by this paper
• The Role of Free Fatty Acids in the Production of Ventricular Arrhythmias after Acute Coronary Artery Occlusion

  1971cited by this paper
• Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

  1968cited by this paper

• Reversible and irreversible changes in the dog heart during acute left ventricular failure due to experimental multifocal ischaemia.

  2009cites this paper
• Main clinical article Persistent angina

  2006cites this paper
• The Role of Multiple Adrenergic Blockade in Coronary Artery Disease and Myocardial Infarction

  2001cites this paper
• Changes in myocardial metabolism and transcardiac electrolytes during simulated ventricular tachycardia: effects of beta-adrenergic blockade.

  1994cites this paper
• Importance of glycolytically produced ATP for the integrity of the threatened myocardial cell

  1990cites this paper
• Myocardial ischemia—Metabolic pathways and implications of increased glycolysis

  1990cites this paper
• Amphiphile‐induced heart muscle‐cell (Myocyte) injury: Effects of intracellular fatty acid overload

  1988cites this paper
• Use of beta adrenoceptor blockade during and after acute myocardial infarction.

  1986cites this paper
• Beta-adrenoceptor blockade in the treatment of coronary heart disease.

  1986cites this paper
• Pharmacological study of a new hypolipidemic drug of prolonged activity, the tetraester of pantethine with 3-(3-pyridinemethoxycarbonyl)propionic acid.

  1985cites this paper
• Current Status of Interventions Designed to Limit Infarct Size

  1985cites this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cites this paper
• Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.

  1985cites this paper
• Reduction of infarct size. An attractive concept: useful--or possible--in humans?

  1985cites this paper
• Reduction ofinfarct size Anattractive concept: useful- orpossible inhumans?

  1985cites this paper
• Medical management of ischemic heart disease

  1983cites this paper
• Influence of Myocardial Substrate Utilization on the Oxygen Consumption of the Heart

  1982cites this paper
• "Salient metabolic features in the myocardial cell".

  1981cites this paper
• [Dynamics of the insulin, somatotropic hormone, glucose and free fatty acid content in the blood during a direct myocardial revascularization operation under neuroleptanalgesia].

  1981cites this paper
• The effect of beta-adrenergic blockade on infarct size following experimental coronary occlusion.

  1981cites this paper
• Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.

  1980cites this paper
• Comparative evaluation of some pharmacological properties and side effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid.

  1980cites this paper
• Some aspects of sorbinicate pharmacokinetics.

  1980cites this paper
• Beneficial effect of practolol in preventing adrenaline‐induced systemic and myocardial metabolic changes

  1979cites this paper
• Effect of glucose--insulin--potassium solution on the exercise performance of patients with coronary artery disease.

  1979cites this paper
• Propranolol during the evolution and subsequent ten days of myocardial infarction in man: Hemodynamic, initial cardiac energetic, and neurohumoral responses

  1979cites this paper
• Metabolic response of the heart in acute myocardial infarction in man.

  1978cites this paper
• Correlation between the plasma concentration of free nicotinic acid and some of its pharmacological effects in the fasted rat after an oral dose of sorbinicate and of nicotinic acid.

  1978cites this paper
• Metabolic Heart Disease With Special Reference to Carbohydrate Metabolism in Health and Disease

  1977cites this paper
• Effect of Increased Free Fatty Acids on Myocardial Oxygen Extraction and Angina Threshold during Atrial Pacing

  1977cites this paper
• Cardiac metabolism in myocardial ischaemia.

  1977cites this paper
• [Recent aspects on basic drug therapy of acute myocardial infarct].

  1977cites this paper
• Reduction of infarct size An attractive concept : useful-or possible in humans ?

  year unknowncites this paper